Christina Rau
GlaxoSmithKline (Germany)(DE)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Multiple Myeloma Research and Treatments, PI3K/AKT/mTOR signaling in cancer, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Proteome survey reveals modularity of the yeast cell machinery(2006)2,561 cited
- → Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling(2009)2,067 cited
- → Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors(2007)1,041 cited
- → Identifying drug targets in tissues and whole blood with thermal-shift profiling(2020)188 cited
- → A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation(2012)143 cited
- → Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor(2019)87 cited
- → Multiple cyclophilins involved in different cellular pathways mediate HCV replication(2009)84 cited
- → Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors(2015)83 cited
- → A Chemical Probe for the ATAD2 Bromodomain(2016)75 cited
- → Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells(2019)58 cited